A Study Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Type 1 Diabetes
Interventions
DEVICE

Dexcom G7 rtCGM

The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 CGM System or G7) is a glucose monitoring system that continuously measures glucose in the interstitial fluid. It aids in the detection of episodes of hyperglycemia and hypoglycemia, facilitating both acute and long-term therapy adjustments

DIAGNOSTIC_TEST

Capillary Blood glucose Testing (POC)

POC glucose meters measure whole blood and convert the results to plasma glucose concentrations, which is the standardized form used in clinical practice.

Trial Locations (1)

30303

RECRUITING

Grady Memorial Hospital, Atlanta

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

Emory University

OTHER